Cline submits international patent application for StemCART therapy product
Cline Scientific (Spotlight Stock Market: CLINE B) today announces it has submitted an international PCT patent application covering methods related to the StemCART cartilage therapy project.This application is an extension to the patent application submitted to the European Patent Authority announced on the 28[th] of March 2020. “Our unique method and product have the potential to provide much-needed treatment to patients across the world. This is a vital step in fulfilling Cline’s strategy to gain strong protection for our groundbreaking stem-cell methods using our surface technology.”